| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |